Related Experiment Video
Updated: Aug 19, 2026

Y-27632 Enriches the Yield of Human Melanocytes from Adult Skin Tissues
Published on: July 8, 2020
FGF-2 blocks TGF-beta1-mediated suppression of Bcl-2 in normal melanocytes
Maria von Willebrand1, Klaus Köhler, Tuomo Alanko
1Department of Dermatology, Helsinki University Central Hospital, University of Helsinki, PB160, 00029 HUS, Finland. marie.vonwillebrand@helsinki.fi
Abstract:
Normal melanocytes require growth support provided by the adjacent basement membrane. In contrast, nevus cells and melanoma cells survive in the dermis, and in vitro on a soft collagen gel. Transforming growth factor-beta1 (TGF-beta1) produced by melanocytes themselves induces apoptosis in normal melanocytes cultured on collagen gel, an effect that can be counteracted by fibroblast growth factor-2 (FGF-2). The purpose of this study was to investigate the mechanisms by which FGF-2 counteracts the apoptotic signals from TGF-beta1 in melanocytes cultured on collagen gel. We report that FGF-2 did not interfere with the signal transduction from the TGF-beta1 receptors to SMAD2/3 proteins. Instead, TGF-beta1 decreased the level of Bcl-2 in normal melanocytes cultured on collagen gel, and FGF-2 reversed the TGF-beta1-mediated reduction in the level of Bcl-2. In nevus and melanoma cells, TGF-beta1 was unable to induce a decrease in the level of Bcl-2, and treatment with FGF-2 did not cause an increase in the level of Bcl-2 in nevus or melanoma cells. In conclusion, our results suggest that a reduction in the level of the anti-apoptotic Bcl-2 is involved in the execution of apoptosis induced by TGF-beta1 in normal melanocytes cultured on collagen gel and that FGF-2 can prevent TGF-beta1 from causing this reduction.
Insights
Fibroblast growth factor-2 (FGF-2) prevents transforming growth factor-beta1 (TGF-beta1)-induced apoptosis in normal melanocytes by maintaining Bcl-2 levels. This mechanism is specific to normal melanocytes, not melanoma cells.
Area of Science:
- Cell Biology
- Dermatology
- Molecular Biology
Background:
- Normal melanocytes rely on basement membrane support for survival.
- Nevus and melanoma cells exhibit altered survival mechanisms, thriving in dermis or on collagen gels.
- Transforming growth factor-beta1 (TGF-beta1) induces apoptosis in normal melanocytes on collagen gels, an effect counteracted by fibroblast growth factor-2 (FGF-2).
Purpose of the Study:
- To elucidate the mechanisms by which FGF-2 counteracts TGF-beta1-induced apoptosis in melanocytes cultured on collagen gel.
Main Methods:
- Investigated signal transduction pathways from TGF-beta1 receptors to SMAD2/3 proteins.
- Assessed the impact of TGF-beta1 and FGF-2 on Bcl-2 protein levels in normal melanocytes, nevus cells, and melanoma cells cultured on collagen gel.
Main Results:
- FGF-2 did not affect TGF-beta1 signal transduction to SMAD2/3 proteins.
- TGF-beta1 reduced Bcl-2 levels in normal melanocytes, while FGF-2 reversed this reduction.
- TGF-beta1 did not decrease Bcl-2 levels in nevus or melanoma cells, and FGF-2 had no effect on Bcl-2 in these cells.
Conclusions:
- Reduced Bcl-2 levels are implicated in TGF-beta1-induced apoptosis of normal melanocytes on collagen gels.
- FGF-2 mitigates TGF-beta1-induced apoptosis by preventing the reduction of anti-apoptotic Bcl-2 protein.
Related Concept Videos
TGF - β Signaling Pathway
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
Mitogens and the Cell Cycle
Pigmentation
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
